SCHEMBL16115770

SCHEMBL16115770

Cc1nnc(C(=O)c2cc(Cl)cc(OCc3ccccc3)c2)o1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX4 Q96LA9 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ BRD4 O60885 1/20 0.44
▸ MAOB P27338 5/20 0.43
▸ NR4A2 P43354 3/20 0.42
▸ RXRA P19793 1/20 0.42
▸ RXRB P28702 1/20 0.42
▸ RXRG P48443 1/20 0.42
▸ MAOA P21397 3/20 0.42
▸ SRD5A2 P31213 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MITF O75030 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16137689 0.87 KMT2A (0.47) MRGPRX4MEN1KMT2ABRD4MAOB
SCHEMBL16114823 0.83 MRGPRX4 (0.40) MRGPRX4MEN1KMT2ABRD4MAOB
SCHEMBL16114824 0.83 MRGPRX4 (0.40) MRGPRX4MEN1KMT2ABRD4MAOB
SCHEMBL1172003 0.79 MRGPRX4 (0.54) MRGPRX4MAOBNR4A2SRD5A2KDM4E
SCHEMBL16137781 0.79 BRD4 (0.38) MRGPRX4MEN1KMT2ABRD4MAOB
SCHEMBL7420476 0.77 LMNA (0.62) MRGPRX4MEN1KMT2AMAOBNR4A2
SCHEMBL7428565 0.76 MEN1 (0.79) MRGPRX4MEN1KMT2AMAOBNR4A2
SCHEMBL16137683 0.75 MEN1 (0.62) MRGPRX4MEN1KMT2AMAOBNR4A2
SCHEMBL14018084 0.74 PARP10 (0.63) MRGPRX4MEN1KMT2AMAOBNR4A2
SCHEMBL13590516 0.74 PLA2G4B (0.49) MEN1KMT2ABRD4MAOBNR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2978754-B1 BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2017-05-10 — — EP disclosed
EP-2978754-B1 BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2017-05-10 — — EP disclosed
EP-2978747-B1 BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2017-04-19 — — EP disclosed
EP-2978747-B1 BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2017-04-19 — — EP disclosed
EP-2978747-A1 BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2016-02-03 — — EP disclosed
EP-2978754-A1 BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2016-02-03 — — EP disclosed
WO-2014154727-A1 BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2014-10-02 — — WO disclosed
WO-2014154727-A1 BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2014-10-02 — — WO disclosed
WO-2014154726-A1 BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2014-10-02 — — WO disclosed
WO-2014154726-A1 BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2014-10-02 — — WO disclosed
Send feedback